Loading...
The authors present a randomized, double-blind trial comparing lamotrigine with placebo as adjunctive therapy for recurrent primary generalized tonic-clonic (PGTC) seizures in 117 patients (age ≥2 years) already receiving one or two antiepileptic drugs (AEDs). Eighty-seven patients (74%) completed this manufacturer-funded study. After an 8-week baseline phase during which seizure frequency was assessed, participants underwent a 7- or 12-week dose-escalation phase, followed by a 12-week dose-maintenance phase. Patient age and use of concomitant AEDs determined the rate of drug escalation and target dose. The primary endpoint was the change from baseline in average monthly PGTC seizure frequency. An important secondary endpoint was seizure re…